Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEUCOVORIN Cause Malignant neoplasm progression? 733 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 733 reports of Malignant neoplasm progression have been filed in association with LEUCOVORIN (LEUCOVORIN CALCIUM). This represents 2.9% of all adverse event reports for LEUCOVORIN.

733
Reports of Malignant neoplasm progression with LEUCOVORIN
2.9%
of all LEUCOVORIN reports
204
Deaths
151
Hospitalizations

How Dangerous Is Malignant neoplasm progression From LEUCOVORIN?

Of the 733 reports, 204 (27.8%) resulted in death, 151 (20.6%) required hospitalization, and 26 (3.5%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEUCOVORIN. However, 733 reports have been filed with the FAERS database.

What Other Side Effects Does LEUCOVORIN Cause?

Diarrhoea (2,594) Neutropenia (2,291) Nausea (1,977) Neuropathy peripheral (1,557) Disease progression (1,456) Fatigue (1,443) Vomiting (1,441) Off label use (1,390) Thrombocytopenia (1,181) Pyrexia (1,148)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which LEUCOVORIN Alternatives Have Lower Malignant neoplasm progression Risk?

LEUCOVORIN vs LEUCOVORIN\LEUCOVORIN LEUCOVORIN vs LEUPROLIDE LEUCOVORIN vs LEVALBUTEROL LEUCOVORIN vs LEVAMISOLE LEUCOVORIN vs LEVAQUIN

Related Pages

LEUCOVORIN Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression LEUCOVORIN Demographics